NemoClinics is an academic platform applying new effective methodologies to characterize mouse models in vivo at birth.
Newborn mice phenotyping
We have developed a novel phenotyping platform for newborn mice. This platform allows high-throughput screening tests able to characterize genetically engineered rodent models. Picture: non invasive cardio-respiratory monitoring for mice pups.
© NemoClinics
NemoClinics operations are conducted at Robert Debré Pediatric Hospital in Paris, in a laboratory of the French National Institute of Health and Medical Research (Inserm) and Université Paris Cité.
We have developed novel devices for newborn mice allowing high-throughput screening tests for genetically engineered rodent models
NemoClinics supplies a comprehensive in vivo screening methodology for new candidate drugs and paediatric indications
Contact
Director: Boris Matrot
Scientific advisor: Nelina Ramanantsoa
Technical specialist: Thomas Bourgeois
NemoClinics – Inserm UMR1141
Hôpital Robert Debré
48 Bd Sérurier
75019 Paris
France
contact
Technology
Services
Expertise
À lire aussi
Breaking news for Central Congenital Hypoventilation Syndrome
In collaboration with Dr. Muriel Thoby-Brisson (Université de Bordeaux, Institut de Neurosciences Cognitives et Intégratives d’Aquitaine, CNRS), and thanks to Fondation Air Liquide, Association Française du syndrome d'Ondine and start-up company ATMOSR, team NeoPhen...
Project – CCHS Foundation 2021
Team SleepCmd, in collaboration with team NeuroDev (Dr. Andrée Delahaye), receive support from the CCHS Foundation in 2022 to study the genetic dysregulations that could be associated with Congenital Central Hypoventilation Syndrome (CCHS). Members of the SleepCmd and...
Read more
Conference Postponed Alexandra Benchoua from I-Stem : Human pluripotent stem cell models for high-throughput screening of therapeutic molecules and precision medicine in neurodevelopmental disorders.
Meeting Room 6th floor Bingen Building and Visio https://u-paris.zoom.us/j/84730677369?pwd=AFdhdI6alNWLbXub7sM1DJ33yUIOYN.1 - Summary séminaire A-Benchoua _27-nov-2025 english
New Golgipathy identified in NeuroDev team
The NeuroDev team publishes an article in Life Science Alliance [1] identifying the first human pathogenic variant of GORASP1, the gene encoding the Golgi stacking protein GRASP65, and demonstrating its consequences on glycosylation and mitotic progression. [1] S....
Job opportunity within The Integrative Genomics in Neurodevelopment group
The Integrative Genomics in Neurodevelopment group is seeking a highly motivated post-doctoral researcher. Check out the opportunity here: Post-doc researcher position in Computational Biology
Sleep2Develop research program
The Sleep2Develop program investigates the role of sleep as a promotor of neurodevelopment and identifies the sleep determinants of childhood development. This is rephrased as Sleep(to)Develop? or Sleep(to)Develop! Our sleep research combines clinical and...